Clin2
NCT07251491Possibly a fitRecruiting

Psilocybin for depression after spinal cord injury

Spinal Cord InjuryDepression - Major Depressive DisorderVeteran

Treatments studied

Part of Brain & nervous system, Injuries & trauma, Pain clinical trials.

This trial tests whether psilocybin (a substance found in certain mushrooms) can help treat depression in people with a spinal cord injury. You would receive the study drug in a controlled setting, and your progress would be monitored closely.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
30 people
Ages
22 years and older
Study type
Interventional

Who can take part

  • You have had a spinal cord injury for at least one year
  • You have been diagnosed with depression
  • You are at least 22 years old and weigh at least 110 pounds
  • You can read and speak English fluently
  • You are willing to stop taking your current antidepressant under a doctor's supervision

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06442423Recruiting· Phase 1
Psilocybin study for people with psychiatric symptoms

This trial tests if psilocybin, a substance found in certain mushrooms, can help people with various mental health symptoms that affect daily life. You would take a single dose in a supervised setting and be monitored for changes in your mood and well-being.

New Haven, Connecticut
NCT07566104Not yet recruiting· Phase 2
Group therapy with psilocybin for depression

This study tests whether psilocybin—a psychedelic compound—combined with group therapy can help people with depression. Participants receive guided psilocybin sessions at UCLA and attend group therapy to process the experience.

Los Angeles, California
NCT07582120Not yet recruiting· Phase 2
Psilocybin-Assisted Therapy for Depression

This study tests whether psilocybin (a naturally occurring psychedelic compound) combined with therapy can help treat depression. Researchers will give you a single dose of psilocybin in a controlled medical setting while providing psychological support to see if it reduces your depression symptoms.

St Louis, Missouri
NCT06512194Recruiting· Phase 2
Psilocybin for depression study

This trial tests whether psilocybin can help people with major depression who are currently having a depressive episode. It aims to understand how the treatment works and if it is safe and effective.

Edwards, Colorado
NCT07703722Recruiting· Phase 3
Psilocybin and therapy for depression with trauma

This trial tests psilocybin (a compound from certain mushrooms) combined with a structured therapy to see if it helps people with depression linked to trauma. It focuses on how the treatment affects the connection between the gut and brain.

Islamabad, Capital
NCT07226232Recruiting· Phase 3
Psilocybin for veterans with treatment-resistant depression

This study tests whether psilocybin (a psychedelic substance) can help veterans with depression that hasn't improved with standard treatments.

Birmingham, Alabama

Hear when a new Depression - Major Depressive Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.